Mani Larijani
Shrum Chair in Biological Mechanisms of Disease & Associate Professor
Research Interests
Make your next move.
Prepare your application
Review drafts before you send them.
Explore related searches
Articles (7)
The evolutionary arms race between host restriction factors and viral antagonists provides crucial insights into immune system evolution and viral adaptation. This study investigates the structural and evolutionary dynamics of the double-domain restriction factors A3F and A3G and their viral inhibitor, Vif, across diverse primate species. By constructing 3D structural homology models and integrating ancestral sequence reconstruction (ASR), we identified patterns of sequence diversity, structural conservation, and functional adaptation. Inactive CD1 (Catalytic Domain 1) domains displayed greater sequence diversity and more positive surface charges than active CD2 domains, aiding nucleotide chain binding and intersegmental transfer. Despite variability, the CD2 DNA-binding grooves remained structurally consistent with conserved residues maintaining critical functions. A3F and A3G diverged in loop 7’ interaction strategies, utilising distinct molecular interactions to facilitate their roles. Vif exhibited charge variation linked to host species, reflecting its coevolution with A3 proteins. These findings illuminate how structural adaptations and charge dynamics enable both restriction factors and their viral antagonists to adapt to selective pressures. Our results emphasize the importance of studying structural evolution in host–virus interactions, with implications for understanding immune defense mechanisms, zoonotic risks, and viral evolution. This work establishes a foundation for further exploration of restriction factor diversity and coevolution across species.
Year:
2025
Deaminases are versatile enzymes present across all domains of life, playing pivotal roles in metabolism, cellular and organ development, heme and vitamin biosynthesis, toxin modulation, antibiotic degradation, the modification of nucleobases, and the mutation of RNA and DNA. This review explores the structural and functional diversity of deaminases, highlighting their mechanisms and evolutionary adaptations. Deaminases catalyze the removal of amine groups, typically using metal cations and proton shuttles to facilitate hydroxyl group incorporation, with some reactions employing pyridoxal 5'-phosphate (PLP) as a cofactor. The review categorizes deaminases based on their substrates, including porphobilinogen, amino sugars, amino acids, and nucleobases. Particular emphasis is placed on nucleobase deaminases due to their roles in RNA/DNA editing and mutagenesis which have significant implications in immune response, cancer progression, and viral defense mechanisms. Structural insights reveal the diverse evolutionary pathways of these enzymes, from simple single-domain forms to complex multi-domain configurations that enable processive deamination of polynucleotides. Through a comprehensive analysis of deaminase families—PBGD, sugar deaminases, amino acid deaminases, and nucleobase deaminases—this review underscores their biological significance and potential applications in agriculture, medicine, and biotechnology, providing a foundational understanding for future research.
Year:
2025
AID/APOBEC3s mutate dC to dU in ssDNA in the restriction of viruses, creation of antibodies, and when off-target affecting cancers. Little was known of the catalytic pocket dynamics of these enzymes in real time. As such, we utilised molecular dynamics analyses to determine catalytic pocket volumes and states. We found that most AID/APOBECs remain predominantly in either a closed or indeterminate state to varying degrees while A3G-CD2 is predominantly open. This occurs chiefly from the catalytic residues themselves and the loop 1 serine/threonine in the "floor" of the catalytic pocket while other residues of the secondary catalytic loops 1, 3, 5, and 7 aid in these states. Surprisingly, we found that the presupposed stable position of AID's unique α7 (β-state) in contact with the β-sheet and α6 was unstable while the α-state in contact with α6 and loop7 was stable and caused pocket closure. Mutations could cause the destabilisation of the α-state (R171Y and R178D) or stabilisation of the β-state (R190D and R194A). Thus, pocket states are relatively similar in overall cause; however, multiple residues from sec-ondary catalytic loops as well as AID-α7 determine the rates at which these states occur, potentially affecting the chances any AID/APOBEC is able to have catalysis.
Year:
2025
Year:
2024
Year:
2024
APOBEC3A and APOBEC3B genome mutators drive tumor evolution and drug resistance but may also generate neoepitopes for cytotoxic T cells (CTL). Given the extensive polymorphism of Class I HLA, the CTL immunopeptidome, comprised of all 8-11mer peptides presented by an individual’s six HLA class I alleles, varies person-to-person. We predicted the genome-wide impact of APOBEC3A/B-driven mutations on the immunogenicity of the immunopeptidomes of several thousand class I HLA alleles. Analysis of several billion APOBEC3-mediated mutations revealed that HLA class I alleles vary markedly in the susceptibility of their immunopeptidome to mutations. A subset of alleles of A1-A3 and B44 supertype supported increased neoepitopes. Notably, the immunogenicity changes supported by an individual’s HLA class I alleles in response to APOBEC3 mutations predict survival in APOBEC3-mutated tumors and correlate with CTL activation. Thus, immunogenicity changes mediated by APOBEC3s impact survival, making HLA class I genotype a prognostic marker in APOBEC3-mutated tumors.
Year:
2024
Year:
2023
Collaborators (3)
Liliana Davalos
Professor
Stony Brook University
Mehmet Samur
Senior Research Scientist
Dana-Farber Cancer Institute
Jia Liu
Associate Professor
University of Arkansas for Medical Sciences
Make your next move.
Prepare your application
Review drafts before you send them.